37243 CPT® code: payer coverage and prior authorization92 of 92 payer prior-auth lists that name 37243 require prior authorization or set conditions: CarePlus Health Plans, Cigna, Humana, Molina Complete Care (Virginia), Molina Healthcare of Arizona, Molina Healthcare of California, Molina Healthcare of Florida, Molina Healthcare of Idaho, Molina Healthcare of Illinois, Molina Healthcare of Iowa, Molina Healthcare of Michigan, Molina Healthcare of Mississippi, Molina Healthcare of Nevada, Molina Healthcare of New Mexico, Molina Healthcare of Ohio, Molina Healthcare of South Carolina, Molina Healthcare of Texas, Molina Healthcare of Utah, Molina Healthcare of Washington, Molina Healthcare of Wisconsin, and others.
37243 appears in 75 coverage policies from Aetna, Blue Cross & Blue Shield of Mississippi, Blue Cross & Blue Shield of Rhode Island, Blue Cross Blue Shield of Massachusetts, Blue Cross NC, Blue Shield of California, BlueCross BlueShield of South Carolina, Health Care Service Corporation (BCBS IL, TX, OK, NM, MT), Premera Blue Cross, UnitedHealthcare.
| Payer | Policy | Role in policy | Reviewed | Document |
|---|---|---|---|---|
| Aetna | Ablation of Hepatic Lesions (0274) | covered if criteria are met | Jun 8, 2026 | payer document |
| Aetna | Anesthetic and Antiemetic Infusion Pumps (0607) | listed, no stance (range 33016-37799) | Sep 9, 2026 | payer document |
| Aetna | Benign Prostatic Hyperplasia (0079) | covered if criteria are met | Apr 15, 2026 | payer document |
| Aetna | Bupivacaine Liposome (Exparel) (0941) | listed, no stance (range 33010-37799) | Jul 30, 2026 | payer document |
| Aetna | Cardiovascular Ultrafiltration (0741) | listed, no stance (range 33010-37790) | Oct 30, 2025 | payer document |
| Aetna | Embolization: Selected Procedures (0856) | covered if criteria are met | Jan 12, 2026 | payer document |
| Aetna | Fibroid Treatment (0304) | covered if criteria are met | Apr 17, 2026 | payer document |
| Aetna | Liver and Other Neoplasms - Treatment Approaches (0268) | covered if criteria are met | Sep 18, 2026 | payer document |
| Aetna | Negative Pressure Wound Therapy (0334) | listed, no stance (range 33016-37799) | Jun 8, 2026 | payer document |
| Aetna | Nitric Oxide, Inhalational (INO) (0518) | not covered (range 33016-37790) | Jul 2, 2026 | payer document |
| Aetna | Peripheral Atherectomy and Thrombectomy Devices (0295) | covered if criteria are met (range 37220-37247) | Apr 16, 2026 | payer document |
| Aetna | Stereolithographic Models and Implants (0613) | listed, no stance (range 33010-37790) | Sep 3, 2026 | payer document |
| Aetna | Ultrasound Guidance – Selected Indications (0952) | not covered | Apr 27, 2026 | payer document |
| Blue Cross & Blue Shield of Mississippi | Occlusion Of Uterine Arteries Using Transcatheter Embolization (L.4.01.417) | covered if criteria are met | payer document | |
| Blue Cross & Blue Shield of Mississippi | Prostate Artery Embolization For Benign Prostatic Hyperplasia | unproven / investigational | payer document | |
| Blue Cross & Blue Shield of Mississippi | Radioembolization For Primary And Metastatic Tumors Of The Liver | covered if criteria are met | payer document | |
| Blue Cross & Blue Shield of Mississippi | Transcatheter Arterial Chemoembolization To Treat Primary Or Metastatic Liver Malignancies | covered if criteria are met | payer document | |
| Blue Cross & Blue Shield of Rhode Island | Miscellaneous Vascular Embolization Procedures | covered if criteria are met | Apr 15, 2026 | payer document |
| Blue Cross Blue Shield of Massachusetts | Transcatheter Arterial Chemoembolization (634) | listed, no stance | payer document | |
| Blue Cross NC | Chemoembolization of the Hepatic Artery, Transcatheter Approach | listed, no stance | May 1, 2026 | payer document |
| Blue Cross NC | Congenital Heart Defect, Repair Devices | listed, no stance | Jun 1, 2026 | payer document |
| Blue Cross NC | Ovarian and Internal Iliac Vein Embolization, Ablation and Sclerotherapy | listed, no stance | Mar 1, 2026 | payer document |
| Blue Cross NC | Radioembolization for Primary and Metastatic Tumors of the Liver | listed, no stance | May 1, 2026 | payer document |
| Blue Shield of California | Prostate Artery Embolization for Benign Prostatic Hyperplasia (7.01.55) | listed, no stance | payer document | |
| BlueCross BlueShield of South Carolina | Occlusion of Uterine Arteries Using Transcatheter Embolization (CAM 40111) | listed, no stance | Aug 1, 2026 | payer document |
| BlueCross BlueShield of South Carolina | Radioembolization for Primary and Metastatic Tumors of the Liver (CAM 80143) | listed, no stance | Oct 1, 2025 | payer document |
| BlueCross BlueShield of South Carolina | Surgical and Minimally Invasive Treatments for Urinary Outlet Obstruction Due to Benign Prostatic Hyperplasia (BPH) (CAM 139) 52649 | Prostate laser enucleation | listed, no stance | Mar 1, 2026 | payer document |
| BlueCross BlueShield of South Carolina | Transcatheter Arterial Chemoembolization To Treat Primary or Metastatic Liver Malignancies (CAM 80111) | listed, no stance | Aug 1, 2026 | payer document |
| Health Care Service Corporation (BCBS IL, TX, OK, NM, MT) | Genicular Artery Embolization (SUR705.048) | listed, no stance | Jul 15, 2025 | payer document |
| Health Care Service Corporation (BCBS IL, TX, OK, NM, MT) | Prostate Artery Embolization for Benign Prostatic Hyperplasia (SUR710.027) | listed, no stance | Jul 1, 2026 | payer document |
| Health Care Service Corporation (BCBS IL, TX, OK, NM, MT) | Radioembolization for Primary and Metastatic Tumors of the Liver (RAD601.047) | listed, no stance | Nov 15, 2025 | payer document |
| Health Care Service Corporation (BCBS IL, TX, OK, NM, MT) | Transcatheter Arterial Chemoembolization to Treat Primary or Metastatic Liver Malignancies (THE801.022) | listed, no stance | Dec 1, 2025 | payer document |
| Premera Blue Cross | Prostate Artery Embolization for Benign Prostatic Hyperplasia (7.01.55) | listed, no stance | Mar 10, 2026 | payer document |
| Premera Blue Cross | Radioembolization for Primary and Metastatic Tumors of the Liver (8.01.521) | listed, no stance | Sep 7, 2026 | payer document |
| Premera Blue Cross | Transcatheter Arterial Chemoembolization (TACE) to Treat Primary or Metastatic Liver Malignancies (8.01.11) | listed, no stance | Sep 21, 2026 | payer document |
| UnitedHealthcare | Abnormal Uterine Bleeding and Uterine Fibroids (2026T0442VV) Uterine Fibroids | listed, no stance | Jan 1, 2026 | payer document |
| UnitedHealthcare | Abnormal Uterine Bleeding and Uterine Fibroids (CS002.AG) Uterine Fibroids | listed, no stance | Nov 1, 2025 | payer document |
| UnitedHealthcare | Abnormal Uterine Bleeding and Uterine Fibroids (for Idaho Only) (CS002ID.C) Uterine Fibroids | listed, no stance | May 1, 2026 | payer document |
| UnitedHealthcare | Abnormal Uterine Bleeding and Uterine Fibroids (for Kansas Only) (CS002KS.02) Uterine Fibroids | listed, no stance | Nov 1, 2025 | payer document |
| UnitedHealthcare | Abnormal Uterine Bleeding and Uterine Fibroids (for Kentucky Only) (CS002KY.10) Uterine Fibroids | listed, no stance | Nov 1, 2025 | payer document |
| UnitedHealthcare | Abnormal Uterine Bleeding and Uterine Fibroids (for Nebraska Only) (CS002NE.AG) Uterine Fibroids | listed, no stance | Dec 1, 2025 | payer document |
| UnitedHealthcare | Abnormal Uterine Bleeding and Uterine Fibroids (for New Jersey Only) (CS002NJ.AE) Uterine Fibroids | listed, no stance | Nov 1, 2025 | payer document |
| UnitedHealthcare | Abnormal Uterine Bleeding and Uterine Fibroids (for New Mexico Only) (CS002NM.C) Uterine Fibroids | listed, no stance | Nov 1, 2025 | payer document |
| UnitedHealthcare | Abnormal Uterine Bleeding and Uterine Fibroids (for North Carolina Only) (CSNCT0442.06) Uterine Fibroids | listed, no stance | Nov 1, 2025 | payer document |
| UnitedHealthcare | Abnormal Uterine Bleeding and Uterine Fibroids (for Ohio Only) (CS002OH.D) Uterine Fibroids | listed, no stance | Dec 1, 2025 | payer document |
| UnitedHealthcare | Abnormal Uterine Bleeding and Uterine Fibroids (for Pennsylvania Only) (CS002PA.AE) Uterine Fibroids | listed, no stance | Dec 1, 2025 | payer document |
| UnitedHealthcare | Abnormal Uterine Bleeding and Uterine Fibroids (for Tennessee Only) (CS002TN.AF) Uterine Fibroids | listed, no stance | Nov 1, 2025 | payer document |
| UnitedHealthcare | Prostate Services and Procedures and Impotence Treatment (MMP075.14) Prostate Artery Embolization (PAE) for Benign Prostatic Hyperplasia (BPH) Related Lower Urinary Tract Symptoms (LUTS) | listed, no stance | Sep 1, 2026 | payer document |
| UnitedHealthcare | Prostate Surgeries and Interventions (CS334.H) | listed, no stance | Jul 1, 2026 | payer document |
| UnitedHealthcare | Prostate Surgeries and Interventions (2026T0618P) | listed, no stance | Jun 1, 2026 | payer document |
| UnitedHealthcare | Prostate Surgeries and Interventions (for Idaho Only) (CS334ID.C) | listed, no stance | Jul 1, 2026 | payer document |
| UnitedHealthcare | Prostate Surgeries and Interventions (for Kansas Only) (CS334KS.02) | listed, no stance | Jul 1, 2026 | payer document |
| UnitedHealthcare | Prostate Surgeries and Interventions (for Kentucky Only) (CS334KY.12) | listed, no stance | Jul 1, 2026 | payer document |
| UnitedHealthcare | Prostate Surgeries and Interventions (for Nebraska Only) (CS334NE.I) | listed, no stance | Jul 1, 2026 | payer document |
| UnitedHealthcare | Prostate Surgeries and Interventions (for New Jersey Only) (CS334NJ.G) | listed, no stance | Jul 1, 2026 | payer document |
| UnitedHealthcare | Prostate Surgeries and Interventions (for New Mexico Only) (CS334NM.D) | listed, no stance | Jul 1, 2026 | payer document |
| UnitedHealthcare | Prostate Surgeries and Interventions (for North Carolina Only) (CSNCT0705.09) | listed, no stance | Aug 1, 2026 | payer document |
| UnitedHealthcare | Prostate Surgeries and Interventions (for Ohio Only) (CS334OH.E) | listed, no stance | Jul 1, 2026 | payer document |
| UnitedHealthcare | Prostate Surgeries and Interventions (for Pennsylvania Only) (CS334PA.H) | listed, no stance | Jul 1, 2026 | payer document |
| UnitedHealthcare | Prostate Surgeries and Interventions (for Tennessee Only) (CS334TN.H) | listed, no stance | Jul 1, 2026 | payer document |
| UnitedHealthcare | Radiation and Oncologic Procedures (MMP077.17) Implantable Beta-Emitting Microspheres for Treatment of Malignant Tumors | listed, no stance | Sep 1, 2026 | payer document |
| UnitedHealthcare | Transarterial Radioembolization (TARE)/ Selective Internal Radiation Therapy (SIRT) for the Treatment of Malignant Cancers of the Liver (CS060NE.O) | listed, no stance | Feb 1, 2026 | payer document |
| UnitedHealthcare | Transarterial Radioembolization (TARE)/ Selective Internal Radiation Therapy (SIRT) for the Treatment of Malignant Cancers of the Liver (CS060PA.O) | listed, no stance | Feb 1, 2026 | payer document |
| UnitedHealthcare | Transarterial Radioembolization (TARE)/ Selective Internal Radiation Therapy (SIRT) for the Treatment of Malignant Cancers of the Liver (2026T0445BB) | listed, no stance | Jan 1, 2026 | payer document |
| UnitedHealthcare | Transarterial Radioembolization (TARE)/ Selective Internal Radiation Therapy (SIRT) for the Treatment of Malignant Cancers of the Liver (CS060NJ.M) | listed, no stance | Jan 1, 2026 | payer document |
| UnitedHealthcare | Transarterial Radioembolization (TARE)/ Selective Internal Radiation Therapy (SIRT) for the Treatment of Malignant Cancers of the Liver (CS060NM.C) | listed, no stance | Jan 1, 2026 | payer document |
| UnitedHealthcare | Transarterial Radioembolization (TARE)/ Selective Internal Radiation Therapy (SIRT) for the Treatment of Malignant Cancers of the Liver (CS060LA.M) | listed, no stance | Mar 1, 2026 | payer document |
| UnitedHealthcare | Transarterial Radioembolization (TARE)/ Selective Internal Radiation Therapy (SIRT) for the Treatment of Malignant Cancers of the Liver (CS060.O) | listed, no stance | Jan 1, 2026 | payer document |
| UnitedHealthcare | Transarterial Radioembolization (TARE)/ Selective Internal Radiation Therapy (SIRT) for the Treatment of Malignant Cancers of the Liver (for North Carolina Only) (CSNCT0445.03) | listed, no stance | Jan 1, 2026 | payer document |
| UnitedHealthcare | Transarterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT) for the Treatment of Malignant Cancers of the Liver (for Idaho Only) (CS060ID.B) | listed, no stance | May 1, 2026 | payer document |
| UnitedHealthcare | Transarterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT) for the Treatment of Malignant Cancers of the Liver (for Kansas Only) (CS060KS.02) | listed, no stance | Jan 1, 2026 | payer document |
| UnitedHealthcare | Transarterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT) for the Treatment of Malignant Cancers of the Liver (for Kentucky Only) (CS060KY.10) | listed, no stance | May 1, 2026 | payer document |
| UnitedHealthcare | Transarterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT) for the Treatment of Malignant Cancers of the Liver (for Ohio Only) (CS060OH.D) | listed, no stance | Jan 1, 2026 | payer document |
| UnitedHealthcare | Transarterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT) for the Treatment of Malignant Cancers of the Liver (for Tennessee Only) (CS060TN.N) | listed, no stance | Jan 1, 2026 | payer document |
| UnitedHealthcare | Uterine Services and Procedures (MMP098.11) UAE for Uterine Fibroids | listed, no stance | Sep 1, 2026 | payer document |
From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.